Ovarian Cancer Radiomics Approach in CT Led Evaluation

When patients have suspected or confirmed ovarian cancer standard treatment will involve surgery and chemotherapy. However, as with any treatment, it is challenging to predict treatment response in advance. Before treatment, all patients have a CT scan to describe where the cancer is in order to guide the treatment. There is now a new way to analyse routine scans using advanced computing methods, which may give more information about the ovarian cancer. This is called radiomics which analyses features in scans that are not visible to the naked eye. Our group at Imperial College London has worked on developing radiomic models to better understand ovarian cancer. This study aims to determine whether the information gained from this new approach would help us to tailor patient treatment plans to better meet the patient's individual needs, even more than done already. Furthermore, the aim is to understand how different types of ovarian cancer can correlate with the radiomic findings, which may help develop potential treatments in the future.

NCT Number	NCT06817174
Lead Sponsor	Imperial College Healthcare NHS Trust Collaborators: National Cancer Center, Korea
Conditions	Ovarian Cancer
Enrollment	168 participants
Start Date	2025-02-10
Primary Completion	2032-01 (estimated)
Study Completion	2032-01 (estimated)
Updated on ClinicalTrials.gov	2025-06-27